![Eric Keller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Eric Keller is the founder of Response Pharmaceuticals, Inc., founded in 2020, holding the title of Co-Chairman & Chief Executive Officer since 2020.
Mr. Keller currently holds the position of President & Director at Noveome Biotherapeutics, Inc. since 2022.
Actieve functies van Eric Keller
| Bedrijven | Functie | Begin |
|---|---|---|
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | President | 16-11-2022 |
Response Pharmaceuticals, Inc.
 Response Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutic development company focused on developing treatments for weight management and metabolic disease | Algemeen Directeur | 01-01-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | Health Technology |
Response Pharmaceuticals, Inc.
Response Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutic development company focused on developing treatments for weight management and metabolic disease | Health Technology |
